Literature DB >> 9660996

Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.

C Ardanuy1, J Liñares, M A Domínguez, S Hernández-Allés, V J Benedí, L Martínez-Martínez.   

Abstract

Fifteen isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases (ESBLs) isolated during a nosocomial outbreak were studied. The strains belonged to the same clonal type, as shown by pulsed-field gel electrophoretic analysis of chromosomal DNA. All the isolates were resistant to extended-spectrum cephalosporins, aztreonam, gentamicin, and fluoroquinolones and were susceptible to carbapenems, tobramycin, netilmicin, and amikacin. None of the isolates expressed the OmpK36 porin. Eight isolates, for which the MICs of cefoxitin were > or = 64 micrograms/ml, showed a diminished level or no expression of a 35-kDa porin. The MICs of meropenem, cefotaxime, and cefpirome were three to eight times higher for porin-deficient isolates than for isolates expressing the 35-kDa porin, but the MICs of imipenem increased two times for porin-deficient isolates compared to those for isolates expressing the porin. This MIC increase reverted to a level similar to that for the parental strain when porin-deficient isolates were transformed with the gene coding for the K. pneumoniae porin OmpK36. It is concluded that the high level of resistance to cefoxitin and the increase in the MICs of meropenem, cefotaxime, and cefpirome for the ESBL-producing K. pneumoniae isolates studied are associated with porin deficiency.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660996      PMCID: PMC105658     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase.

Authors:  B Pangon; C Bizet; A Buré; F Pichon; A Philippon; B Regnier; L Gutmann
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

2.  Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.

Authors:  L Gutmann; R Williamson; N Moreau; M D Kitzis; E Collatz; J F Acar; F W Goldstein
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

3.  Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four French hospitals.

Authors:  P Legrand; G Fournier; A Buré; V Jarlier; M H Nicolas; D Decré; J Duval; A Philippon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

Review 4.  Outer membrane barrier as a mechanism of antimicrobial resistance.

Authors:  H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

5.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

6.  Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases.

Authors:  C Peña; M Pujol; C Ardanuy; A Ricart; R Pallares; J Liñares; J Ariza; F Gudiol
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

7.  Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.

Authors:  C Brun-Buisson; P Legrand; A Philippon; F Montravers; M Ansquer; J Duval
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

8.  Emergence of bacterial resistance to cefamandole in vivo due to outer membrane protein deficiency.

Authors:  J A van de Klundert; M H van Gestel; G Meerdink; S de Marie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

9.  A versatile class of positive-selection vectors based on the nonviability of palindrome-containing plasmids that allows cloning into long polylinkers.

Authors:  J Elhai; C P Wolk
Journal:  Gene       Date:  1988-08-15       Impact factor: 3.688

10.  Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae.

Authors:  G A Papanicolaou; A A Medeiros; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

View more
  34 in total

1.  Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains.

Authors:  Stéphane Gayet; Renaud Chollet; Gérard Molle; Jean-Marie Pagès; Jacqueline Chevalier
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  Expression of SHV-2 beta-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems.

Authors:  Brendan Crowley; Vicente J Benedí; Antonio Doménech-Sánchez
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

3.  Role of ISKpn7 and deletions in blaKPC gene expression.

Authors:  Thierry Naas; Gaelle Cuzon; Ha-Vy Truong; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

Review 4.  Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.

Authors:  Louis B Rice
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

5.  Porin Loss Impacts the Host Inflammatory Response to Outer Membrane Vesicles of Klebsiella pneumoniae.

Authors:  Kelli L Turner; Bethaney K Cahill; Sarah K Dilello; Dedra Gutel; Debra N Brunson; Sebastián Albertí; Terri N Ellis
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

6.  First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America.

Authors:  Maria Virginia Villegas; Karen Lolans; Adriana Correa; Carlos Jose Suarez; Jaime A Lopez; Marta Vallejo; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

7.  Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence.

Authors:  Yu-Kuo Tsai; Chang-Phone Fung; Jung-Chung Lin; Jiun-Han Chen; Feng-Yee Chang; Te-Li Chen; L Kristopher Siu
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

8.  Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints.

Authors:  Peng Wang; Fupin Hu; Zizhong Xiong; Xinyu Ye; Demei Zhu; Yun F Wang; Minggui Wang
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

9.  Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.

Authors:  Emma Padilla; Diana Alonso; Antonio Doménech-Sánchez; Cristina Gomez; José Luis Pérez; Sebastián Albertí; Nuria Borrell
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

10.  Role of Klebsiella pneumoniae LamB Porin in antimicrobial resistance.

Authors:  Laura García-Sureda; Carlos Juan; Antonio Doménech-Sánchez; Sebastián Albertí
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.